ATOSSA THERAPEUTICS INC
For the period ended Dec 31, 2023. Filed Apr 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 1, 2024
ATOS$2.13+0.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(amounts in thousands, except share and per share data)
| As of December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $88,460 | $110,890 |
| Restricted cash | 110 | 110 |
| Prepaid materials | 1,487 | 5,247 |
| Prepaid expenses and other current assets | 2,162 | 1,207 |
| Research and development tax rebate receivable | — | 743 |
| Total current assets | 92,219 | 118,197 |
| Investment in equity securities | 1,710 | 4,700 |
| Other assets | 2,323 | 635 |
| Total assets | $96,252 | $123,532 |
| Liabilities and stockholders' equity | ||
| Current liabilities | ||
| Accounts payable | $806 | $2,965 |
| Accrued expenses | 973 | 1,059 |
| Payroll liabilities | 1,654 | 1,525 |
| Other current liabilities | 1,803 | 19 |
| Total current liabilities | 5,236 | 5,568 |
| Total liabilities | 5,236 | 5,568 |
| Commitments and contingencies (Note 13) | ||
| Stockholders' equity | ||
| Convertible preferred stock - $0.001 par value; 10,000,000 shares authorized; 582 shares issued and outstanding as of December 31, 2023 and 2022 | — | — |
| Common stock - $0.18 par value; 175,000,000 shares authorized; 125,304,064 and 126,624,110 shares issued and outstanding as of December 31, 2023 and 2022, respectively | 22,792 | 22,792 |
| Additional paid-in capital | 255,987 | 251,366 |
| Treasury stock, at cost; 1,320,046 and 0 shares of common stock at December 31, 2023 and 2022, respectively | (1,475) | — |
| Accumulated deficit | (186,288) | (156,194) |
| Total stockholders' equity | 91,016 | 117,964 |
| Total liabilities and stockholders' equity | $96,252 | $123,532 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.